Literature DB >> 18064418

Presynaptic receptors for dopamine, histamine, and serotonin.

Thomas J Feuerstein1.   

Abstract

Presynaptic receptors for dopamine, histamine and serotonin that are located on dopaminergic, histaminergic and sertonergic axon terminals, respectively, function as autoreceptors. Presynaptic receptors also occur as heteroreceptors on other axon terminals. Auto- and heteroreceptors mainly affect Ca(2+) -dependent exocytosis from the receptor-bearing nerve ending. Some additionally subserve other presynaptic functions.Presynaptic dopamine, histamine and serotonin receptors are involved in various (patho)physiological conditions. Examples are the following:Dopamine autoreceptors play a role in Parkinson's disease, schizophrenia and drug addiction. Dopamine heteroreceptors affecting the release of acetylcholine and of amino acid neurotransmitters in the basal ganglia are also relevant for Parkinson's disease. Peripheral dopamine heteroreceptors on postganglionic sympathetic terminals influence heart rate and vascular resistance through modulation of noradrenaline release. Blockade of histamine autoreceptors increases histamine synthesis and release and may support higher CNS functions such as arousal, cognition and learning. Peripheral histamine heteroreceptors on C fiber and on postganglionic sympathetic fiber terminals diminish neuropeptide and noradrenaline release, respectively. Both inhibititory effects are beneficial in myocardial ischemia. The inhibition of neuropeptide release also explains the antimigraine effects of some agonists of presynaptic histamine receptors. Upregulation of presynaptic serotonin autoreceptors is probably involved in the pathogenesis of major depression. Correspondingly, antidepressant treatments can be linked with a reduced density of 5-HT autoreceptors. 5-HT Heteroreceptor activation diminishes acetylcholine and GABA release and may therefore increase anxiety. In the periphery, presynaptic 5-HT heteroreceptor agonists shorten migraine attacks by inhibition of the release of neuropeptides from trigeminal afferents, apart from their constrictive action on meningeal vessels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18064418     DOI: 10.1007/978-3-540-74805-2_10

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  21 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  5-HT(1B) receptors inhibit glutamate release from primary afferent terminals in rat medullary dorsal horn neurons.

Authors:  I-S Choi; J-H Cho; C-H An; J-K Jung; Y-K Hur; J-K Choi; I-S Jang
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Heterologous, PKC-Mediated Desensitization of Human Histamine H3 Receptors Expressed in CHO-K1 Cells.

Authors:  Wilber Montejo-López; Nayeli Rivera-Ramírez; Juan Escamilla-Sánchez; Ubaldo García-Hernández; José-Antonio Arias-Montaño
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

4.  Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes.

Authors:  M Mantovani; D J Dooley; A Weyerbrock; R Jackisch; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

Review 5.  Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases.

Authors:  Thomas J Feuerstein; Miriam Kammerer; Carl Hermann Lücking; Andreas Moser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

6.  A search for functional histamine H4 receptors in the human, guinea pig and mouse brain.

Authors:  Monika Feliszek; Valerie Speckmann; Daniel Schacht; Marec von Lehe; Holger Stark; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-10       Impact factor: 3.000

Review 7.  Gestational restraint stress and the developing dopaminergic system: an overview.

Authors:  Carlos J Baier; María R Katunar; Ezequiela Adrover; María Eugenia Pallarés; Marta C Antonelli
Journal:  Neurotox Res       Date:  2012-01-04       Impact factor: 3.911

Review 8.  Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss).

Authors:  Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

Review 9.  The role of D2-autoreceptors in regulating dopamine neuron activity and transmission.

Authors:  C P Ford
Journal:  Neuroscience       Date:  2014-01-23       Impact factor: 3.590

10.  A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H₃ receptor stably expressed in CHO-K1 cells.

Authors:  Cecilia Flores-Clemente; Angélica Osorio-Espinoza; Juan Escamilla-Sánchez; Rob Leurs; Juan-Manuel Arias; José-Antonio Arias-Montaño
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.